Staša Stanković

Educational Background
2019-Present

University of Cambridge (Department of Clinical Medicine, Addenbrookes Hospital)

PhD in Genomic Medicine

2017-2018

University of Cambridge (Wellcome Trust Sanger Institute)

MPhil in Medical Science

2014-2017

University of Oxford and Oxford Brookes University (joined program)

BSc in Biomedical Science

Professional Background
2019-Present

British–Serbian Medical Association – member

2019-Present

British–Serbian Chamber of Commerce, President of BSCC Young Professionals Group

2019-Present

Organisation of Serbian Students Abroad, Director of Internal Affairs

2018-Present

Congenica (BioData Innovation Center, Wellcome Genome Campus), Business Analyst, Innovation Team: “Mainstreaming of Genomic Medicine

2018-Present

Innovation Forum Serbia, Founder

Head of the first healthcare accelerator in Serbia “Imagine IF”

2017-Present

University of Cambridge (Department of Physiology, Development and Neuroscience)

Visiting Scientist

2017-2019

Innovation Forum Cambridge, Business Development Associate

Awards
  • 2019 – Award: Novartis Regional BioCamp 2019 (Slovenia)This award is given to 35 best and most promising young scientists from the Balkan region to participate at prestigious Novartis BioCamp and work with pharma and medical leaders, top scientists, professionals and academics.
  • 2018 – Third place and the most creative business plan at the Cambridge Consulting Network Business Case Competition. University of Cambridge (2018)
  • 2015 – Gatsby Science Summer School, University of Cambridge (2015)This scholarship is given to 80 first year undergraduates selected from 26 research-intensive UK universities with the highest achievements in the first term of the first year of the course.
  • 2014 – “Vuk Karadžić diploma” for the highest achievement in high school (2014)
Publications
  • Combes G, Maciejowski J, Barysz H, Garand C, Gama BL, Alharbi I, Thebault P, Murakami L, Eyers PA, Stanković S, Bolanos-Garcia VM, Earnshaw W, Jallepalli Prasad, Elowe S. (2018). “Mps1 Phosphorylates Its N-terminal Extension to Relieve Autoinhibition and Activate the Spindle Assembly Checkpoint”. Current Biology. 28 (6), 872-883.
  • Stanković S, Pau P, Bolanos-Garcia VM. “Dissecting the structural basis of Mps1 inhibition efficacy for the treatment of cancer”. Manuscript in prep.
Language Skills
  • Serbian  (native)
  • Italian (fluent – diploma from High School, bilingual class in Italian)
  • English (fluent)
  • German (intermediate – Diploma from Primary and High School, B1)
  • Spanish (basic)
    ICG International
    Consulting Group

    The International Consulting Group is a voluntary, non-political, non-governmental and non-profit organisation established for an indefinite period to set and realise goals in the field of civil society development, international, cultural and economic cooperation and education.

    ADDRESS

    Ušće 1/D, 11000 Belgrade, Serbia

    PHONE

    +381 64 523 1577

    EMAIL

    info@icg.org.rs